TABLE 1.
Plasmids used in this study
| Transgene | Selectable marker | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Plasmid (pHD #) | 5′-UTR | ORF | 3′ UTR | 5′ UTR | ORF | 3′ UTR | Promoter | Integration locus | Parent plasmid (pHD #) | Referencesa |
| a(1) Biebinger et al. 1997; (2) L. Storm, D. Horn, and C. Clayton, in prep.; (3) C. Hartmann and C. Clayton, unpubl.; (4) Estévez et al. 2001; (5) this study; (6) Irmer and Clayton 2001; (7) Quijada et al. 2002. | ||||||||||
| bThese plasmids are similar to those described in Estévez et al. (2001) except that the 3′ UTRs following the RNAi stem-loop sequences are from a VSG locus. | ||||||||||
| cThese plasmids are similar to those described in Irmer and Clayton (2001) or Quijada et al. (2002) except that the selectable marker is PAC and the Tet operator sequence is absent. | ||||||||||
| 1313 | EP1 | 2× TetR | ACT, VSG | ACT | BLE | ACT | TUB | 449 | 1, 2 | |
| 514 | EP1 | T7 RNA POL | ACT | ACT | NEO | ACT | TUB | 514 | 3 | |
| 1153b | EP1 | RRP4 RNAi | VSG | ACT | HYG | ACT | EPIT1 | RRNA | 1146 | 4, 5 |
| 1154b | EP1 | RRP45 RNAi | VSG | ACT | HYG | ACT | EPITi | RRNA | 1146 | 4, 5 |
| 1199 | EP1 | CSL4 RNAi | ACT | ACT | HYG | ACT | EPITi | RRNA | 1146 | 4 |
| 1413c | EP1 | CAT | EP1 | ACT | PAC | ΔALD | T7 | RRNA | 774 | 5, 6 |
| 1344c | EP1 | CAT | ACT | ACT | PAC | ΔALD | T7 | RRNA | 789, 1034 | 5, 6 |
| 1414c | EP1 | CAT | ep1ΔURE | ACT | PAC | ΔALD | T7 | RRNA | 775 | 5, 6 |
| 1415c | EP1 | CAT | PGKB | PGKC | PAC | ΔALD | T7 | RRNA | 869 | 5, 7 |
| 1417c | EP1 | CAT | pgkbΔURE | PGKC | PAC | ΔALD | T7 | RRNA | 1044 | 5, 7 |
| 1416c | EP1 | CAT | PPDK | ACT | PAC | ΔALD | T7 | RRNA | 1317 | 5, 7 |
| 1343c | EP1 | CAT | G30C30EP1 | ACT | PAC | ΔALD | T7 | RRNA | 1413, 921 | 5, 6 |










